Centrus Energy Stock Price, News & Analysis

Centrus Energy Corp. (LEU) is an American supplier of nuclear fuel and related services for the nuclear power industry. According to company disclosures and regulatory filings, Centrus focuses on providing low-enriched uranium (LEU), high-assay, low-enriched uranium (HALEU), and nuclear fuel components that support the generation of clean, affordable, carbon-free electricity. The company’s activities are closely tied to efforts to restore U.S.-owned uranium enrichment capacity at industrial scale for both commercial power generation and national security needs.

The company’s business is organized around the supply of nuclear fuel and services. As described in public information, Centrus has historically operated through a Low-Enriched Uranium (LEU) segment and a Technical Solutions segment. The LEU segment includes the sale of separative work units (SWU) and uranium, which are core components of nuclear fuel supply to utilities. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers, including work related to HALEU production under contracts with the U.S. Department of Energy (DOE).

Role in the nuclear fuel cycle

Centrus positions itself as a trusted supplier to nuclear utilities, emphasizing the reliability and diversity of its supply sources. Public statements note that, since 1998, the company has provided its utility customers with more than 1,850 reactor years of fuel, which it equates to more than 7 billion tons of coal. This highlights Centrus’ role in supporting long-term, baseload nuclear generation as part of broader clean energy and energy security objectives.

A key focus for Centrus is the development and deployment of advanced centrifuge technology for uranium enrichment. The company operates the American Centrifuge Plant in Piketon, Ohio, where it is working to expand enrichment capacity. Under a DOE contract initiated in 2019, Centrus constructed a cascade of its AC-100M advanced centrifuges to demonstrate production of HALEU, a next-generation fuel needed for advanced nuclear reactors. The plant became operational in 2023 and continues to produce HALEU under contract with the DOE.

Expansion of U.S. uranium enrichment capacity

Centrus has announced plans for a multi-billion-dollar expansion of its uranium enrichment capacity in Piketon, Ohio. Public disclosures and SEC filings indicate that the expansion is expected to add thousands of additional centrifuges at the American Centrifuge Plant, with the goal of delivering large-scale production of both LEU for existing reactors and HALEU for advanced reactors. The scale and timing of this expansion depend in part on federal funding decisions by the U.S. Department of Energy and the company’s ability to secure private capital.

The company reports that it has secured significant contingent LEU sales commitments from utility customers in the United States and abroad, which are tied to the construction of new enrichment capacity. Centrus also notes that it has raised substantial private capital through convertible note offerings and established an at-the-market equity offering program, providing additional financial flexibility to support its expansion plans.

Manufacturing footprint and job creation

Centrus’ expansion strategy includes both enrichment operations and centrifuge manufacturing. The company has begun domestic centrifuge manufacturing at a facility in Oak Ridge, Tennessee, relying on a U.S.-based manufacturing supply chain. Public statements describe a project that is expected to support:

• Construction and operations jobs at the Piketon, Ohio enrichment site;
• Hundreds of direct jobs at the centrifuge manufacturing plant in Tennessee;
• Additional indirect jobs across a nationwide network of suppliers.

Centrus has also initiated design work on a Training, Operations & Maintenance facility in Piketon, intended to support its growing workforce and the construction and operation of commercial-scale uranium enrichment capacity.

International partnerships and market reach

While Centrus emphasizes its role as a U.S.-owned enrichment company, it also engages in international commercial relationships. The company has disclosed a Memorandum of Understanding with Korea Hydro & Nuclear Power (KHNP) and POSCO International to explore potential investment in its Piketon enrichment expansion and to consider additional supply agreements for LEU and HALEU. Centrus reports that Korea is an important potential export market for U.S. enriched uranium and notes that it has agreed with KHNP to increase the supply volume of LEU under an existing contract, contingent on federal funding for new capacity.

Centrus also references export customers in its description of LEU purchase commitments, indicating that its commercial reach extends beyond the U.S. domestic market. At the same time, the company highlights that almost all global enrichment capacity is currently controlled by foreign, state-owned enterprises, and presents its technology and projects as a means to diversify supply and strengthen U.S. and allied energy security.

Regulatory and market environment

Centrus operates in a highly regulated environment shaped by U.S. and international nuclear, trade, and sanctions regimes. The company has disclosed that it procures LEU under long-term supply contracts, including a contract with a Russian government-owned entity. It has described the impact of U.S. legislation that bans imports of Russian LEU, subject to DOE waivers, and has reported receiving waivers that allow it to import LEU for committed deliveries to U.S. customers through 2027. These regulatory developments are presented as important factors in the company’s supply chain and risk profile.

In addition to commercial considerations, Centrus emphasizes national security aspects of its work. Public information notes that the company’s AC-100M centrifuge technology is U.S.-origin and described as deployment-ready for missions where a U.S. technology is required. The National Nuclear Security Administration has indicated its intent to contract with Centrus for LEU enrichment for national security purposes, underscoring the intersection of the company’s activities with defense-related needs.

Stock listing and corporate status

Centrus Energy Corp. is a publicly traded company. SEC filings state that its Class A common stock trades under the ticker symbol “LEU”. In December 2025, the company announced that the New York Stock Exchange approved the transfer of its listing from NYSE American LLC to the NYSE, with trading on the NYSE commencing on December 4, 2025 under the same symbol. A subsequent Form 25 filing clarifies that the company voluntarily withdrew its securities from listing on NYSE American in connection with this transfer, while maintaining registration and listing on the NYSE.

Business segments and services

Based on available descriptions, Centrus’ activities can be summarized as follows:

• Low-Enriched Uranium (LEU): Sale of SWU and uranium to utility customers under medium- and long-term contracts, including contingent sales commitments that depend on the build-out of new enrichment capacity.
• Technical Solutions: Engineering, design, manufacturing, and related services for government and private sector customers, including work under a HALEU production contract with the DOE. Revenue from this segment includes cost-plus-incentive-fee arrangements tied to specific contracts.
• HALEU production: Demonstration and production of high-assay, low-enriched uranium at the Piketon facility under DOE contracts, with plans to expand to commercial-scale production as part of the broader enrichment expansion.

Investment considerations and risk factors

Centrus’ SEC filings and press releases highlight various factors that can affect its operations and financial performance. These include dependence on key suppliers and contracts, exposure to geopolitical and trade restrictions affecting nuclear fuel imports and exports, the need for substantial public and private investment to expand enrichment capacity, and uncertainties related to government funding for HALEU and LEU production. The company also notes that its backlog of LEU and Technical Solutions contracts extends over many years and that the profitability of its LEU business can vary based on contract timing and market conditions.

Investors and analysts reviewing LEU stock often consider the company’s role in the nuclear fuel supply chain, its progress in deploying U.S.-origin enrichment technology, its long-term contracts and backlog, and its exposure to regulatory and geopolitical developments in the nuclear sector. Official SEC filings, including Forms 10-K, 10-Q, and 8-K, provide detailed information on these topics, while company press releases offer additional context on strategic initiatives, contracts, and capital-raising activities.

Frequently asked questions about Centrus Energy Corp. (LEU)

The following FAQs summarize key points based on publicly available information and regulatory filings.